Fundraising FoxViewPoint Therapeutics
San Francisco, US · Founded 2014 · Delaware corporation · 4 known investors
Find your way into ViewPoint Therapeutics
Sign up to see every warm intro you have to ViewPoint Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ViewPoint Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
ViewPoint Therapeutics was founded in 2014 by Leah Makley.
LM
Leah MakleyFounder
EH
Ed HurwitzExecutive
JE
Jason E. GestwickiNamed on SEC filing
Board
DC
ET
Emmett T. Cunningham, Jr.Board director
MB
Mark Blumenkranz, M.D.Board director
Investors · 4
Biotechnology Value FundreportedSan Francisco
How we know: funding news · press coverage · Not right? Tell us
Mission Bay CapitalreportedSan Francisco
How we know: funding news · press coverage · Not right? Tell us
Red Tree VentureinferredSan Diegovia Heath Lukatch · board
How we know: board seat on SEC Form D · Not right? Tell us
The Rise FundreportedFort Worth
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$24.9M disclosed across 2 rounds · 2016–2018
▶$20.9MraisedMar 2018 · 13 investors · BiotechnologyRule 506(b)
▶$20.9MraisedMar 2018 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Leah MakleyExecutive Officer, Director
- Ed HurwitzDirector
- Peter MoldtDirector
- Emmett T. Cunningham, Jr.Director
- Heath LukatchDirector
- Offering amount
- $35M
- Amount sold
- $20.9M
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$4MraisedMay 2016 · 17 investors · BiotechnologyRule 506(b)
▶$4MraisedMay 2016 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Douglas CrawfordDirector
- Ed HurwitzExecutive Officer, Director
- Emmett T. Cunningham, Jr.Director
- Mark Blumenkranz, M.D.Director
- Jason E. GestwickiDirector
- Leah MakleyExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $4M
- First sale
- Apr 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded ViewPoint Therapeutics?
- ViewPoint Therapeutics was founded by Leah Makley in 2014.
- Who are ViewPoint Therapeutics's investors?
- ViewPoint Therapeutics's investors include Biotechnology Value Fund, Mission Bay Capital, Red Tree Venture, The Rise Fund.
- How much funding has ViewPoint Therapeutics raised?
- ViewPoint Therapeutics has disclosed $24.9M raised across 2 rounds.
- Where is ViewPoint Therapeutics headquartered?
- ViewPoint Therapeutics is headquartered in San Francisco, US.